UBE3C expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.74519978865828E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.28309999994458E-06 |
Normal-vs-Stage2 |
6.684600E-03 |
Normal-vs-Stage3 |
1.87779791716025E-11 |
Normal-vs-Stage4 |
3.2295000007565E-08 |
Stage1-vs-Stage2 |
8.229200E-01 |
Stage1-vs-Stage3 |
5.371900E-04 |
Stage1-vs-Stage4 |
2.026400E-02 |
Stage2-vs-Stage3 |
2.267600E-02 |
Stage2-vs-Stage4 |
7.696300E-02 |
Stage3-vs-Stage4 |
7.625600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.88790008468243E-10 |
Normal-vs-AfricanAmerican |
3.28439999974783E-07 |
Normal-vs-Asian |
7.894200E-01 |
Caucasian-vs-AfricanAmerican |
4.531800E-01 |
Caucasian-vs-Asian |
2.472400E-02 |
AfricanAmerican-vs-Asian |
1.618170E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.12639997329467E-09 |
Normal-vs-Female |
9.40000000060337E-08 |
Male-vs-Female |
7.330400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.681800E-02 |
Normal-vs-Age(41-60Yrs) |
4.52720000376772E-08 |
Normal-vs-Age(61-80Yrs) |
1.58869994937305E-09 |
Normal-vs-Age(81-100Yrs) |
7.19699999596202E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.612000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.106800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.900000E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.980400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.530000E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.766200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.592830E-01 |
Normal-vs-Grade 2 |
4.73339999973454E-07 |
Normal-vs-Grade 3 |
2.14389617170241E-11 |
Normal-vs-Grade 4 |
1.24669999990168E-07 |
Grade 1-vs-Grade 2 |
3.647800E-01 |
Grade 1-vs-Grade 3 |
7.613800E-02 |
Grade 1-vs-Grade 4 |
1.002010E-01 |
Grade 2-vs-Grade 3 |
1.011960E-02 |
Grade 2-vs-Grade 4 |
2.593900E-02 |
Grade 3-vs-Grade 4 |
6.704000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.06099999955356E-07 |
Normal-vs-ccB subtype |
1.60422999999632E-05 |
ccA subtype-vs-ccB subtype |
8.798200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.5175000386073E-09 |
Normal-vs-N1 |
4.943000E-01 |
N0-vs-N1 |
5.410600E-01 |
|
|